Lipoic acid: Energy metabolism and redox regulation of transcription and cell signaling

Journal of Clinical Biochemistry and Nutrition

Volumn 48, Issue 1, 2011, Pages 26-32

  Packer, Lester ^a   Cadenas, Enrique ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

AMPK; Dihydrolipoic acid; Energy; Insulin; Lipoic acid; Mitochondria; PGC1 ; Redox

Indexed keywords

ADENYLATE KINASE; DICHLOROACETIC ACID; DISULFIDE; GLUCOSE TRANSPORTER 4; LEVACECARNINE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PYRUVATE DEHYDROGENASE; RAPAMYCIN; STRESS ACTIVATED PROTEIN KINASE; THIOCTIC ACID; THIOL;

AGING; BRAIN MITOCHONDRION; CELL ENERGY; CELL TRANSPORT; DEGENERATIVE DISEASE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG PENETRATION; ENERGY METABOLISM; ENZYME INHIBITION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HUNTINGTON CHOREA; MAXIMUM PLASMA CONCENTRATION; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; TRANSCRIPTION REGULATION;

EID: 78650727185     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.11-005FR     Document Type: Review

References (80)

1. Reed LJ, De BB, Gunsalus IC, Hornberger CS Jr. Crystalline alpha-lipoic acid; a catalytic agent associated with pyruvate dehydrogenase. Science 1951; 114: 93-94.
2. Patel MS, Packer L, eds. Lipoid acid. energy production, antioxidant activity, and health effects. Boca Raton: CRC Press, Taylor & Francis Group, 2008.
3. Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 2009; 1790: 1149-1160.
4. Koh EH, Cho EH, Kim MS, Park JY, Lee KU. Effects of alpha-lipoic acid on AMP-activated protein kinase in different tissues: therapeutic implications for the metabolic syndrome. In: Patel MS, Packer L, eds. Lipoic Acid: Energy Production, Antioxidant Activity, and Health Effects. Boca Raton, Florida: CRC Press/Taylor & Francis Group, 2008; 495-519.
5. Ziegler D. Painful diabetic neuropathy: advantage of novel drugs over old drugs? Diabetes Care 2009; 32 Suppl 2: S414-S419.
6. Maczurek AE, Krautwald M, Steele ML, and et al. Lipoic acid as a novel treatment for mild cognitive impairment and early-stage Alzheimer's disease. In: Packer L, Sies H, Eggersdorfer M, Cadenas E, eds. Micronutrients and Brain Health. Boca Raton, Florida: CRC Press/Taylor & Francis Group, 2009; 133-147.
7. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001; 30: 1191-1212.
8. Kemp M, Go YM, Jones DP. Nonequilibrium thermodynamics of thiol/ disulfide redox systems: A perspective on redox systems biology. Free Radic Biol Med 2008; 44: 921-937.
9. Jones DP. Redefining oxidative stress. Antioxid Redox Signal 2006; 8: 1865-1879.
10. Packer L, Witt EH, Tritschler HJ. Alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 1995; 19: 227-250.
11. Go YM, Jones DP. Redox clamp model for study of extracellular thiols and disulfides in redox signaling. Methods Enzymol 2010; 474: 165-179.
12. Han D, Handelman G, Marcocci L, and et al. Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors 1997; 6: 321-338.
13. Han D, Tritschler HJ, Packer L. Alpha-lipoic acid increases intracellular glutathione in a human T-lymphocyte Jurkat cell line. Biochem Biophys Res Commun 1995; 207: 258-264.
14. May JM, Qu ZC, Nelson DJ. Uptake and reduction of alpha-lipoic acid by human erythrocytes. Clin Biochem 2007; 40: 1135-1142.
15. Machlin LJ, Bendich A. Free radical tissue damage: protective role of antioxidant nutrients. FASEB J 1987; 1: 441-445.
16. Balamurugan K, Vaziri ND, Said HM. Biotin uptake by human proximal tubular epithelial cells: cellular and molecular aspects. Am J Physiol Renal Physiol 2005; 288: F823-F831.
17. Takaishi N, Yoshida K, Satsu H, Shimizu M. Transepithelial transport of alpha-lipoic acid across human intestinal Caco-2 cell monolayers. J Agric Food Chem 2007; 55: 5253-5259.
18. Han D, Handelman GJ, Packer L. Analysis of reduced and oxidized lipoic acid in biological samples by high-performance liquid chromatography. Meth Enzymol 1995; 251: 315-325.
19. Moini H, Tirosh O, Park YC, Cho KJ, Packer L. R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes. Arch Biochem Biophys 2002; 397: 384-391.
20. Cho KJ, Moini H, Shon HK, Chung AS, Packer L. Alpha-lipoic acid decreases thiol reactivity of the insulin receptor and protein tyrosine phosphatase 1B in 3T3-L1 adipocytes. Biochem Pharmacol 2003; 66: 849-858.
21. Lodge JK, Packer L. Natural sources of lipoic acid in plant and animal tissues. In: Packer L, Hiramatsu M, Yoshikawa K, eds. Antioxidant Food Supplements in Human Health. New York: Academic Press, 1999; 121-134.
22. Carlson DA, Smith AR, Fischer SJ, Young KL, Packer L. The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects. Altern Med Rev 2007; 12: 343-351.
23. Suzuki YJ, Aggarwal BB, Packer L. Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells. Biochem Biophys Res Commun 1992; 189: 1709-1715.
24. Cho KJ, Moon HE, Moini H, Packer L, Yoon DY, Chung AS. Alpha-lipoic acid inhibits adipocyte differentiation by regulating pro-adipogenic transcription factors via mitogen-activated protein kinase pathways. J Biol Chem 2003; 278: 34823-34833.
25. Müller C, Dünschede F, Koch E, Vollmar AM, Kiemer AK. Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway. Am J Physiol Gastrointest Liver Physiol 2003; 285: G769-G778. (Pubitemid 37151239)
26. Zhang L, Xing GQ, Barker JL, and et al. Alpha-lipoic acid protects rat cortical neurons against cell death induced by amyloid and hydrogen peroxide through the Akt signalling pathway. Neuroscience Lett 2001; 312: 125-128. (Pubitemid 32972139)
27. Zhang WJ, Wei H, Hagen T, Frei B. Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc Natl Acad Sci USA 2007; 104: 4077-4082. (Pubitemid 47181581)
28. Zhang WJ, Bird KE, McMillen TS, LeBoeuf RC, Hagen TM, Frei B. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice. Circulation 2008; 117: 421-428.
29. Zhang DD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 2006; 38: 769-789.
30. Khan CR, Suzuki R. Insulin action in the brain and the pathogenesis of Alzheimer's disease. In: Craft S, Christen Y, eds. Diabetes, Insulin, and Alzheimer's Disease. Heidelberg: Springer, 2010; 1-20.
31. Luo RZ, Beniac DR, Fernandes A, Yip CC, Ottensmeyer FP. Quaternary structure of the insulin-insulin receptor complex. Science 1999; 285: 1077-1080. (Pubitemid 129515455)
32. Ueki K, Yamamoto-Honda R, Kaburagi Y, and et al. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J Biol Chem 1998; 273: 5315-5322.
33. Czech MP, Corvera S. Signaling mechanisms that regulate glucose transport. J Biol Chem 1999; 274: 1865-1868. (Pubitemid 29061327)
34. Konrad D, Somwar R, Sweeney G, and et al. The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes 2001; 50: 1464-1471. (Pubitemid 32500181)
35. Yaworsky K, Somwar R, Ramlal T, Tritschler HJ, Klip A. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alphalipoic acid in 3T3-L1 adipocytes. Diabetologia 2000; 43: 294-303. (Pubitemid 30163472)
36. Hirosumi J, Tuncman G, Chang L, and et al. A central role for JNK in obesity and insulin resistance. Nature 2002; 420: 333-336.
37. Qiao LY, Goldberg JL, Russell JC, Sun XJ. Identification of enhanced serine kinase activity in insulin resistance. J Biol Chem 1999; 274: 10625-10632.
38. Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 2000; 275: 9047-9054.
39. Gupte AA, Bomhoff GL, Morris JK, Gorres BK, Geiger PC. Lipoic acid increases heat shock protein expression and inhibits stress kinase activation to improve insulin signaling in skeletal muscle from high-fat-fed rats. J Appl Physiol 2009; 106: 1425-1434.
40. Shay KP, Hagen TM. Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by alpha-lipoic acid through PI3 kinase, PTEN, and PP2A. Biogerontology 2009; 10: 443-456.
41. Scheid MP, Woodgett JR. PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol 2001; 2: 760-768.
42. Bijur GN, Jope RS. Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem 2003; 87: 1427-1435.
43. Barksdale KA, Bijur GN. The basal flux of Akt in the mitochondria is mediated by heat shock protein 90. J Neurochem 2009; 108: 1289-1299.
44. Mookherjee P, Quintanilla R, Roh MS, Zmijewska AA, Jope RS, Johnson GV. Mitochondrial-targeted active Akt protects SH-SY5Y neuroblastoma cells from staurosporine-induced apoptotic cell death. J Cell Biochem 2007; 102: 196-210.
45. Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004; 18: 1926-1945.
46. Hahn-Windgassen A, Nogueira V, Chen CC, Skeen JE, Sonenberg N, Hay N. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J Biol Chem 2005; 280: 32081-32089.
47. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 2007; 450: 736-740.
48. Zhou Q, Lam PY, Han D, Cadenas E. c-Jun N-terminal kinase regulates mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in primary cortical neurons. J Neurochem 104: 325-335.
49. Zhou Q, Lam PY, Han D, Cadenas E. Activation of c-Jun-N-terminal kinase and decline of mitochondrial pyruvate dehydrogenase activity during brain aging. FEBS Lett 2009; 583: 1132-1140.
50. Gibson GE, Blass JP, Beal MF, Bunik V. The alpha-ketoglutarate dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration. Mol Neurobiol 2004; 31: 43-63.
51. Korotchkina LG, Patel MS. Pyruvate dehydrogenase complex regulation and lipoic acid. In: Patel MS, Packer L, eds. Lipoic Acid: Energy Production, Antioxidant Atcivity, and Health Effects. Boca Raton: CRC Press, 2008; 149-165.
52. Korotchkina LG, Sidhu S, Patel MS. R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase. Free Radic Res 2004; 38: 1083-1092.
53. Humphries K, Yoo Y, Szweda LI. Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal. Biochemistry 1998; 37: 552-557.
54. Humphries KM, Szweda LI. Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. Biochemistry 1998; 37: 15835-15841.
55. Applegate MA, Humphries KM, Szweda LI. Reversible inhibition of alpha-ketoglutarate dehydrogenase by hydrogen peroxide: glutathionylation and protection of lipoic acid. Biochemistry 2008; 47: 473-478.
56. Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 2007; 8: 774-785.
57. Poels J, Spasić MR, Callaerts P, Norga KK. Expanding roles for AMP-activated protein kinase in neuronal survival and autophagy. Bioessays 2009; 31: 944-952.
58. Lee WJ, Kim M, Park HS, and et al. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. Biochem Biophys Res Commun 2006; 340: 291-295.
59. Jager S, Handschin C, St-Pierre J, Spiegelman BM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci USA 2007; 104: 12017-12022.
60. Cantó C, Gerhart-Hines Z, Feige JN, and et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009; 458: 1056-1060.
61. Haigis MC, Guarente LP. Mammalian sirtuins - emerging roles in physiology, aging, and calorie restriction. Genes Dev 2006; 20: 2913-2921.
62. Jeninga EH, Schoonjans K, Auwerx J. Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility. Oncogene 2010; 29: 4617-4624.
63. Wang Y, Li X, Guo Y, Chan L, Guan X. Alpha-Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1alpha signaling in the skeletal muscle of aged mice. Metabolism 2010; 59: 967-976.
64. Reznick RM, Zong H, Li J, and et al. Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metab 2007; 5: 151-156.
65. Chng HT, New LS, Neo AH, Goh CW, Browne ER, Chan EC. Distribution study of orally administered lipoic acid in rat brain tissues. Brain Res 2009; 1251: 80-86.
66. Saeed U, Durgadoss L, Valli RK, Joshi DC, Joshi PG, Ravindranath V. Knockdown of cytosolic glutaredoxin 1 leads to loss of mitochondrial membrane potential: implication in neurodegenerative diseases. PLoS One 2008; 3: e2459.
67. Liu J. The effects and mechanisms of mitochondrial nutrient alpha-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: an overview. Neurochem Res 2008; 33: 194-203.
68. Hirai K, Aliev G, Nunomura A, and et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 2001; 21: 3017-3023.
69. Moreira PI, Siedlak SL, Wang X, and et al. Autophagocytosis of mitochondria is prominent in Alzheimer disease. J Neuropathol Exp Neurol 2007; 66: 525-532.
70. Frölich L, Götz ME, Weinmüller M, and et al. (r)-, but not (s)-alpha lipoic acid stimulates deficient brain pyruvate dehydrogenase complex in vascular dementia, but not in Alzheimer dementia. J Neural Transm 2004; 111: 295-310.
71. McGahon BM, Martin DS, Horrobin DF, Lynch MA. Age-related changes in LTP and antioxidant defenses are reversed by an alpha-lipoic acid-enriched diet. Neurobiol Aging 1999; 20: 655-664.
72. Long J, Gao F, Tong L, Cotman CW, Ames BN, Liu J. Mitochondrial decay in the brains of old rats: ameliorating effect of alpha-lipoic acid and acetyl-L-carnitine. Neurochem Res 2009; 34: 755-763.
73. Aliev G, Liu J, Shenk JC, and et al. Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats. J Cell Mol Med 2009; 13: 320-333.
74. Siedlak SL, Casadesus G, Webber KM, and et al. Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease. Free Radic Res 2009; 43: 156-164.
75. Shenk JC, Liu J, Fischbach K, and et al. The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease. J Neurol Sci 2009; 283: 199-206.
76. Suchy J, Chan A, Shea TB. Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance. Nutr Res 2009; 29: 70-74.
77. Andreassen OA, Ferrante RJ, Dedeoglu A, Beal MF. Lipoic acid improves survival in transgenic mouse models of Huntington's disease. Neuroreport 2001; 12: 3371-3373.
78. Andreassen OA, Ferrante RJ, Huang HM, and et al. Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease. Ann Neurol 2001; 50: 112-117.
79. Christie LA, Opii WO, Head E, Araujo JA, de Rivera C, Milgram NW, Cotman CW. Short-term supplementation with acetyl-L-carnitine and lipoic acid alters plasma protein carbonyl levels but does not improve cognition in aged beagles. Exp Gerontol 2009; 44: 752-759.
80. Abdul HM, Butterfield DA. Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. Free Radic Biol Med 2007; 42: 371-384.